http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-202091951-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-07 |
| filingDate | 2019-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-202091951-A1 |
| titleOfInvention | METHODS FOR TREATMENT OF CANCER USING A COMBINATION OF ANTIBODY BASED ON PLATINUM AND ANTIBODY CONJUGATE TO TISSUE FACTOR WITH A DRUG |
| abstract | The present invention relates to a platinum-based agent (e.g., carboplatin) in combination with an antibody-drug conjugate that binds to tissue factor (TF) (e.g. tizotumab-vedotin) and their use in methods of treating cancer such as urinary bladder and cervical cancer. The present invention also relates to compositions and kits comprising a platinum-based agent (eg, carboplatin) and an antibody-drug conjugate that binds to TF (eg, tizotumab-vedotin) for use in the treatment of cancer such as bladder cancer and cancer cervix. |
| priorityDate | 2018-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.